Celator Pharmaceuticals Announces Pricing Of A $12.9M Public Offering Of Common Stock And Warrants To Purchase Common Stock
October 23, 2014 at 07:02 AM EDT
Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today ...
